Anxiety as a Risk Factor for Cardiovascular Diseases by Silvia Raquel Soares Ouakinin
February 2016 | Volume 7 | Article 251
Frontiers Commentary
published: 24 February 2016
doi: 10.3389/fpsyt.2016.00025
Frontiers in Psychiatry | www.frontiersin.org
Edited by: 
Ripu D. Jindal, 
University of Alabama at Birmingham 











Ouakinin SRS (2016) Anxiety as a 
Risk Factor for Cardiovascular 
Diseases. 
Front. Psychiatry 7:25. 
doi: 10.3389/fpsyt.2016.00025
anxiety as a risk Factor for 
Cardiovascular Diseases
Silvia Raquel Soares Ouakinin*
University Clinic of Psychiatry and Medical Psychology, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
Keywords: anxiety, cardiovascular risk factors, heart rate variability, cardiovascular diseases, emotion regulation
A commentary on 
Anxiety Disorders are Associated with Reduced Heart Rate Variability: a Meta-Analysis 
by Chalmers JA, Quintana DS, Abbott MJ, Kemp AH. Front Psychiatry (2014) 5:80. doi:10.3389/
fpsyt.2014.00080
Potential psychological risk factors for cardiovascular diseases (CVD) can be grouped in three 
domains. The first consists of negative affective states including depression, anxiety, distress, and 
anger, the second includes personality patterns such as Type A behavior pattern and Type D 
personality, and the third comprehends social factors including socioeconomic status and social 
support (1). Anxiety, a significant risk factor for CVD, is recently recognized as a crucial issue in 
younger and older adults, with a causal relation to other risk factors, such as depression, substance 
use, overweight, sleep difficulties, or a sedentary life style (2, 3).
Anxiety disorders, with a 12-month prevalence rate of 17.7% and a higher lifetime prevalence in 
women (30.5%) than men (19.2%), are among the most common psychiatric diagnoses. (4). Several 
anxiety disorders are developed during childhood and tend to persist if not adequately treated. 
They include social anxiety disorder, panic disorder, agoraphobia, and generalized anxiety disorder, 
among others (5).
The association between anxiety and cardiovascular adverse events in patients with CVD is still 
not clear (6–12); however, recent reviews provide evidences according to which in coronary heart 
disease, anxiety can increase the risk of major cardiac events and mortality (1, 2, 13).
The physiological pathways that could explain the impact of psychosocial risk factors on the 
cardiovascular system are not always evident; therefore, this commentary highlights the findings 
of an association between anxiety disorders and reduced heart rate variability (HRV) by Chalmers 
et al. (14), aiming to contribute for explaining the comorbidity between anxiety and CVD. HRV 
represents an indicator of the complex relation between sympathetic and parasympathetic branches 
of the autonomic nervous system (ANS) and its influence on heart functioning. Low HRV can be 
conceptualized both as a precursor of disease and a risk factor, with adverse effects on cardiovascular 
health (15).
In “Anxiety Disorders are Associated with Reduced Heart Rate Variability: A Meta-Analysis,” 
Chalmers et  al. (14) described a meta-analysis of 36 studies in order to examine “the impact of 
anxiety on resting HRV a psychophysiological marker of health and well-being.” They rely on the 
neurovisceral integration model to explain the relation between HRV and anxiety, presenting mixed 
findings to support this assumption. For clarification, they point to the advantages of a meta-analytic 
procedure. Their results highlight that “anxiety disorders are associated with significant reductions in 
HRV,” with a “small-to-moderate effect size.” Authors discuss those findings in the context of the neu-
rovisceral integration model and the polyvagal theory, pointing to the relevance of the vagal function 
decrease in the pathophysiology of a state of allostatic load, in response to a threatening environ-
ment. Addressing some limitations of this meta-analytic review, they indicate the reduced number 
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of studies in different anxiety disorders and the importance of 
depression and anxiety comorbidity. In the summary, they refer 
the implications for patient’s health in a long-term perspective 
and the need for considering preventive strategies (14).
Despite the differences between anxiety disorders, anxious 
individuals, in general, overestimate the danger of perceived 
fearful situations, and this cognitive appraisal is associated with a 
state of arousal and autonomic activation, an adaptive response to 
prepare the organism to a “fight or flight” reaction (16). However, 
the nature of the appraised threats does not always imply such 
a response. Then, the adaptive response turns maladaptive and 
potentially toxic. The generalization of this pattern is linked to 
the concept of anxiety and increased risk for CVD, diabetes, and 
inflammatory disorders.
Also, evidences for the association between psychological 
factors, such as depression, hostility, or anger, and the metabolic 
syndrome, as a risk cluster for those diseases, strengthen the need 
to address these relations (17).
Evidences in literature emphasize that brain regions responsi-
ble for processing threatening information can trigger biological 
stress-response systems, such as the hypothalamic–pituitary–
adrenal (HPA) axis and the ANS. Associated to threat-related 
brain activity, the sympathetic nervous branch of the ANS is 
upregulated with an increase in blood pressure and greater cat-
echolamine release from adrenal medulla and sympathetic nerves 
(norepinephrine). On the contrary, the parasympathetic division 
is downregulated as shown by decreases in respiratory sinus 
arrhythmia. Activation of the central and peripheral systems in 
response to acute social-evaluative threat also generates increased 
systemic inflammation (16, 18).
Hyperactivity in autonomic response patterns can increase 
the expression of anxiety symptoms, the interoception of body 
signals, and central-periphery interactions (19).
Neuroimaging data support the hypothesis of what Eccles 
et  al. called a neurovisceral phenotype model, associating 
brain regions (the amygdala, cingulate and insula cortex, basal 
ganglia, and ventromedial prefrontal cortex), subjective feelings, 
and patterns of affective reactivity in different clinical entities 
(20). According to Thayer, HRV may display the flexibility of a 
balanced physiologic regulation or an index of healthy cardiac 
function, thus offering a sign of degree of adaptive regulation of 
the “brain’s integrative system” and the organism adaptive skills 
facing complex interactions with the external milieu (21).
Emotion regulation strategies have been extensively 
researched as risk factors for the onset of coronary heart diseases. 
In a Swedish National Study including 46,393 men, in a follow-up 
of 38 years, Potijk et al. found that in the presence of a parental 
history of heart disease, poor emotion control in young adults 
(18–20 years) was a predictive factor of long-term risk, even con-
trolling for lifestyle and biomedical risk factors (22). Interestingly, 
greater difficulties in emotion regulation have been linked to 
lower resting vagal-mediated HRV (23), reinforcing their role in 
the association between major or minor stressors, negative affect, 
and heart reactivity. The finding that cardiovascular risk mark-
ers are related to parasympathetic activity, in adolescents aged 
11–14 years, suggests that HRV could be a potential marker for 
discriminating adolescents at risk (24).
The implications of poor emotion regulation strategies, 
higher levels of anxiety or depression, and psychophysiological 
dysregulation seem to be the most relevant in prevention and 
treatment, with significant impact in morbidity and mortality in 
anxious as well as in CVD patients. Additional important issues, 
such as gender-related differences in cardiovascular risk and 
early determinants of autonomic response in adulthood, deserve 
further investigation.
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